Coverage
-
August 24, 2023
A California federal judge on Thursday applauded attorneys for investors in Geron Corp. as he gave final approval to a settlement with the biotechnology company and its CEO over claims they hid negative results of a clinical drug trial, saying, "This is not the greatest case ever, and you managed to get $24 million out of it."
3 other articles on this case.
View all »